Tirzepatide cuts risk of diabetes by 94% in adults with ... - CNN
Aug 20, 2024 · A three-year study of tirzepatide – a medication approved in the US as Mounjaro for diabetes and Zepbound for weight loss – found that when adults who had prediabetes and …
FDA says this weight loss drug shortage is over, but ... - CBS News
Oct 23, 2024 · Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies …
Mounjaro leads to significantly more weight loss than Ozempic, …
Jul 8, 2024 · People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study. …
News Release
It is not known if Mounjaro can be used in people who have had inflammation of the pancreas (pancreatitis). Mounjaro is not for use in people with type 1 diabetes. It is not known if …
Eli Lilly's tirzepatide cuts heart failure risks, company says - NBC News
Aug 1, 2024 · Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the …
Ozempic Could Prevent Diabetes. Should We Use It For That?
10 hours ago · By Dani Blum. Nov. 13, 2024 Updated 6:00 p.m. ET. A new study adds to mounting evidence showing that drugs like Ozempic don’t just treat diabetes — they can also …
News Release - Eli Lilly and Company
FDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes. Mounjaro delivered superior A1C …
FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity ... - CNN
Nov 8, 2023 · The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss, according to a news release from the FDA. Made by Eli Lilly, it’s part of a new class of drugs …
FDA Says Mounjaro, Zepbound Shortage Has Ended: What to Know - Healthline
Aug 7, 2024 · Zepbound and Mounjaro have been on the Food and Drug Administration's shortage list for months. In response, manufacturer Eli Lilly spent billions ramping up …
A new version of the diabetes drug Mounjaro can ... - Associated Press News
Nov 8, 2023 · A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration …